Confirm Trade
Overview
DT1
Swing
Pre-market briefing → AI bull/bear debate → Bracket orders. Holds days. yfinance + Finnhub scanner, DeepSeek + Sonnet LLM.
$0.00
$100,000 capital · 0 trades
Win Rate
Avg Win
Avg Loss
Sharpe
Max risk2%/trade
Positions5 max
Daily halt-5%
Schedule6AM M-F
Hold timeDays
EMA9/20/50
DT2
Momentum
Scanz PMH scanner → Scoring 0-100 → Adaptive ATR stops + multi-level scaling (⅓ at T1, T2, trail). Intraday only, closes 3:30 PM ET.
$0.00
$100,000 capital · 0 trades
Win Rate
Avg R/R
Max DD
0%
Scans/d
~210
Max size$5K/pos
Positions3 max
Daily halt-3%
Scan freqq2min
Score min55+
StopATR 1.5×
DT3
Human Loop
DT2 scanner fork → Candidates to KV → Telegram alert → Review spider graph + scores → Buy/Deny with 5 min countdown, 3% drift invalidates.
$0.00
$100,000 capital · 0 alerts
Alerts
0
Approved
0
Denied
0
Hit Rate
Min score40+
Timeout5 min
Drift max3%
FeedbackKV 30d
Scanner
PMH Momentum Breakout
Fri Feb 28 · Close 4:00 PM ET · 7 results
Trade Alerts
82
ENSC
$0.62 · R/R 3.2:1 · +62% gap
Pending
4:32
Ensysce Biosciences Inc.
Clinical-stage biotech developing abuse-resistant opioid prodrugs (TAAP/MPAR platforms). Focus on reducing opioid abuse while maintaining pain relief efficacy.
Healthcare Biotech Phase 2 Micro-cap
Mkt Cap
$18.2M
Float
6.8M
Low float
Short %
14.2%
2.1 days to cover
Rel Vol
48.2×
vs 10d avg
$ Volume
$175M
Avg Vol
5.9M
10-day
Prev Close
$0.40
Open
$0.64
+60% gap
Day Range
$0.57–$0.77
VWAP
$0.65
Price below
RSI (14)
78
Overbought zone
ATR
$0.08
Stop basis
EMA 9
$0.61
Above ✓
EMA 20
$0.44
Above ✓
EMA 50
$0.38
Above ✓
PM High
$0.71
Key level
Insider %
8.3%
Inst %
12.1%
Entry
$0.62
Stop
$0.57
Target
$0.78
R/R
3.2:1
Catalyst
85
News quality & impact — earnings, FDA, contracts, analyst upgrades
Technical Setup
80
EMA alignment, VWAP position, gap structure, R/R ratio
Share Structure
78
Float size, insider/institutional ownership, short interest squeeze potential
PMH Breakout
88
Price vs pre-market high — breaking above with volume confirms continuation
Tape Reading
75
100-tick order flow — buy/sell pressure, block trades, bid/ask spread
Volume Profile
82
Relative volume vs 10d avg, dollar volume, pre-market participation
Latest News
Ensysce Biosciences announces positive Phase 2 trial results for PF614, abuse-resistant opioid prodrug
PR Newswire · 6:01 AM · Primary catalyst
ENSC stock surges 60%+ pre-market on clinical data; analyst sees potential FDA fast-track designation
Benzinga · 7:45 AM
Short squeeze potential flagged — 14.2% SI with 2.1 days to cover on low 6.8M float
StockTwits trending · 8:30 AM
79
BATL
$5.52 · R/R 2.4:1 · +23% gap
Approved
Battalion Oil Corporation
Independent E&P company focused on the Delaware Basin (Permian). Operates ~28,000 net acres with growing production profile and low operating costs.
Energy E&P Permian Basin Small-cap
Mkt Cap
$92M
Float
12.4M
Short %
6.8%
1.4 days cover
Rel Vol
8.7×
vs 10d avg
$ Volume
$310M
Avg Vol
6.4M
10-day
Prev Close
$4.15
Open
$5.11
+23% gap
Day Range
$4.41–$6.00
VWAP
$5.28
Above ✓
RSI (14)
72
ATR
$0.48
Stop basis
EMA 9
$5.10
Above ✓
EMA 20
$4.42
Above ✓
EMA 50
$3.95
Above ✓
PM High
$5.44
Broke ✓
Insider %
18.6%
Inst %
42.3%
Entry
$5.52
Stop
$4.86
Target
$7.10
R/R
2.4:1
Catalyst
72
Strong quarterly production growth, revenue beat, raised guidance
Technical Setup
84
All EMAs aligned bullish, above VWAP, clean gap structure
Share Structure
82
12.4M float, 18.6% insider, 6.8% short — tight supply
PMH Breakout
76
Broke PM high of $5.44 with volume confirmation
Tape Reading
80
Strong buy pressure 68/32, block trades on bid side
Volume Profile
78
8.7× relative volume, $310M dollar volume, heavy participation
Latest News
Battalion Oil Q4 production up 18% QoQ to 14,200 BOE/d, beats consensus by 12%
GlobeNewswire · 6:00 AM · Primary catalyst
Company raises FY26 capex guidance, announces $15M share buyback program
SEC Filing 8-K · 6:00 AM
47
UVIX
$6.28 · R/R 1.2:1 · +10% gap
Denied
2x Long VIX Futures ETF (Volatility Sciences)
Leveraged ETF tracking 2× daily VIX short-term futures. Designed for short-term hedging, not directional momentum plays. Subject to contango decay — loses value over time by design.
⚠ ETF — Not Equity Volatility 2× Leveraged Contango decay
AUM
$142M
Float
N/A
ETF — no float
Short %
N/A
Not applicable
Rel Vol
3.2×
vs 10d avg
$ Volume
$430M
Expense
1.65%
Annual
Prev Close
$5.80
Open
$6.39
+10% gap
Day Range
$6.05–$6.54
VWAP
$6.32
Near
VIX
22.4
Underlying
Contango
-4.2%
Monthly decay
1W Return
+18%
Mean-reverting
1M Return
-22%
Decay in action
3M Return
-48%
Structural loser
Entry
$6.28
Stop
$6.05
Target
$6.56
R/R
1.2:1
Catalyst
30
No company-specific news — macro VIX spike on broad market sell-off
Technical Setup
52
Gap up but no follow-through, price fading from open, weak R/R 1.2:1
Share Structure
20
ETF — no float, no short squeeze, creation/redemption kills momentum
PMH Breakout
55
Briefly broke PM high but immediately rejected, no hold
Tape Reading
48
Mixed flow — institutional selling into retail buying, arb desks active
Volume Profile
60
Decent volume but ETF volume ≠ conviction — authorized participants create shares
Latest News
VIX spikes to 22.4 on tariff fears and weak economic data; broad market sells off
Reuters · 8:15 AM · Macro
UVIX sees heavy retail inflows — analysts warn leveraged VIX products are "designed to go to zero"
MarketWatch · 9:00 AM · Warning
Feedback: "ETF not equity — no float dynamics, contango decay, no company catalyst. R/R too weak at 1.2:1."
Activity
Bought BATL × 906 @ $5.52 · Score 79
Mon 9:41 AM · DT3
Approved by you
Denied UVIX · Score 47 — "ETF not equity"
Mon 9:38 AM · DT3
Denied
DT3 deployed · Human-in-the-loop active
Feb 28, 6:00 PM
DT2 deployed · Momentum scanner
Feb 28, 9:14 PM
DT1 deployed · Swing strategy
Feb 28, 6:42 PM
$
Paper accounts funded · $100K × 3
Feb 28, 5:30 PM